Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Laurus Labs Ltd soars 1.75%, Gains for third straight session
Laurus Labs Ltd is quoting at Rs 1227.6, up 1.75% on the day as on 12:49 IST on the NSE. The stock is up 108.49% in last one year as compared to a 0.68% gain in NIFTY and a 14.53% gain in the Nifty Pharma index.
Dividend alert! Last date to buy these 10 stocks before they go ex-record date. Do you own?
Investors have a final opportunity today to purchase shares of 10 companies before they go ex-record date for dividends tomorrow, May 8. Notable companies include Central Bank of India, Laurus Labs, NALCO, and Premier Energies, with dividend payouts varying across the listed firms.
Market Trading Guide: 5 stock ideas for gains up to 11% on Tuesday
Nifty ended higher amid positive election sentiment but faced resistance near 24,200. Analysts see support at 24,000, maintaining a bullish bias above key levels. Experts recommend selective trades, suggesting buying stocks like Adani Ports and Laurus Labs, while cautioning on CDSL weakness.
Laurus Labs Q4 Results: Cons PAT increased 19% to Rs 279 crore, revenue rises 5%
Laurus Labs reported a 19% year-on-year jump in net profit to Rs 279 crore for the March quarter, with revenue rising 5% to Rs 1,812 crore. Full-year net profit surged 148% to Rs 889 crore, driven by strong growth in its CDMO and Generics divisions. The company also announced an interim dividend of Rs 1.20 per share.
Q4 Results LIVE Updates: Sundram Fasteners profit up 30%; ESAF SFB NII grows 20%
Q4 Results LIVE Updates: Today is the busiest day in terms of quarterly results this week. The big earnings reaction of the day comes from Bajaj Finance where brokerages have raised their targets and even upgraded the stock, along with Waaree Energies, who also issued its guidance for FY27. The biggest result of the day comes from Hindustan Unilever (HUL), followed by Adani twins on the Nifty (Ports & Enterprises), Bajaj Finserv, ACC, Laurus Labs, Dr. Lal Pathlabs, RailTel, Newgen Software and others. Follow for all the Live updates.
Nifty Pharma index soars 7% thus far in February; nears 52-week high
Thus far in the month of February 2026, Laurus Labs surged 13%, while Sun Pharmaceutical Industries and Torrent Pharmaceuticals soared 11% each.
Laurus Labs shares are up 100% in the last 12 months and Motilal Oswal sees further upside
Motilal Oswal expects Laurus Labs to end financial year 2026 with a Profit After Tax (PAT) of ₹850 crore and reach ₹1,150 crore by financial year 2028, implying a Compounded Annual Growth Rate (CAGR) of 16% by this period.
Momentum Stocks: Visa Steel hits upper circuit; Adani Ports, Laurus Labs at new high
Visa Steel, California Software, Omax Autos, Axiscades Technologies, Sterlite Technologies, DCM Shriram Fin were locked in the upper band, reflecting strong demand and limited supply—often a sign of bullish near-term sentiment.
Trade Spotlight: How should you trade Concord Biotech, Max Healthcare Institute, Laurus Labs, Bank of Maharashtra, Castrol India, and others on May 5?
Overall, the market is expected to remain range-bound until the previous week’s high is taken out convincingly. Below are some short-term trading ideas to consider.
Buy Laurus Labs; target of Rs 1370: Motilal Oswal
Motilal Oswal is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 1370 in its research report dated April 30, 2026.
Momentum Stocks: Jindal Saw, HFCL, Syrma SGS, Laurus Labs, hit 52-week high
IZMO, BF Utilities, Agarwal Industrial Corporation were locked in the upper band, reflecting strong demand and limited supply—often a sign of bullish near-term sentiment.
Taking Stock: Sensex, Nifty end flat ahead of RBI policy; consumer durables, capital goods shine
More than 120 stocks touched their 52-week high on the BSE, including Cemindia Projects, Nippon Life India Asset Management, Jindal Saw, HFCL, Syrma SGS, Laurus Labs, Polycab, Vodafone Idea, Federal Bank, IFCI, JK Bank, Welspun Corp, RBL Bank, among others.